Measles Research Today is a free monthly online journal that collates and summarizes the latest research about Measles, including details on german measles, symptoms, vaccine, treatment, rubella.

Volume 5 (2008), Issue 4 (April)

1. Treatment of medulloblastoma with modified measles virus.
   J Neurosurg Pediatrics, 1(4): A353-4. [Abstract] [Full-text]
2. Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model.
   Int J Epidemiol, 37(2): 356-67. [Abstract] [Full-text]
3. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
   Pediatr Infect Dis J, 27(4): 341-6. [Abstract] [Full-text]
4. Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States.
   Pediatrics, 121(4): e836-43. [Abstract] [Full-text]
5. Case of fulminant-SSPE associated with measles genotype D7 from India: An autopsy study.
   Neuropathology. [Abstract] [Full-text]
6. Failure to Detect Measles Virus Ribonucleic Acid in Bone Cells from Patients with Paget's Disease.
   J Clin Endocrinol Metab, 93(4): 1398-401. [Abstract] [Full-text]
7. Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.
   Clin Vaccine Immunol, 15(4): 697-706. [Abstract] [Full-text]
8. Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study.
   BMJ, 336(7647): 754-7. [Abstract] [Full-text]
9. A multiplex TaqMan PCR assay for the detection of measles and rubella virus.
   J Virol Methods, 149(2): 246-50. [Abstract] [Full-text]
10. Feasibility of global measles eradication after interruption of transmission in the Americas.
    Expert Rev Vaccines, 7(3): 355-62. [Abstract] [Full-text]
11. Paramyxoviruses: different receptors - different mechanisms of fusion.
    Trends Microbiol, 16(4): 135-7. [Abstract] [Full-text]
12. Measles on the edge: coastal heterogeneities and infection dynamics.
    PLoS ONE, 3(4): e1941. [Abstract] [Full-text]
13. Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses.
    Vaccine, 26(17): 2164-74. [Abstract] [Full-text]
14. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005.
    Vaccine, 26(17): 2111-8. [Abstract] [Full-text]
15. Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus.
    Virology, 374(1): 71-81. [Abstract] [Full-text]
16. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin.
    J Virol, 82(9): 4630-7. [Abstract] [Full-text]
17. Selective association of multiple sclerosis with infectious mononucleosis.
    Mult Scler, 14(3): 307-13. [Abstract] [Full-text]
18. Modeling of cancer virotherapy with recombinant measles viruses.
    J Theor Biol, 252(1): 109-22. [Abstract] [Full-text]
19. DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes.
    PLoS Pathog, 4(4): e1000049. [Abstract] [Full-text]
20. The C, V and W proteins of Nipah virus inhibit minigenome replication.
    J Gen Virol, 89: 1300-8. [Abstract] [Full-text]
21. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    J Infect Dis, 197(7): 950-6. [Abstract] [Full-text]
22. Backward bifurcations and multiple equilibria in epidemic models with structured immunity.
    J Theor Biol, 252(1): 155-65. [Abstract] [Full-text]
23. Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150).
    J Biol Chem, 283(17): 11763-71. [Abstract] [Full-text]
24. Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.
    Biochim Biophys Acta, 1785(2): 217-31. [Abstract] [Full-text]
25. Rubeola keratitis: a photographic study of corneal lesions.
    Cornea, 27(4): 411-6. [Abstract] [Full-text]
26. Reliability of medical students' vaccination histories for immunisable diseases.
    BMC Public Health, 8: 121. [Abstract] [Full-text]
27. Interpreting changes in measles genotype: the contribution of chance, migration and vaccine coverage.
    BMC Infect Dis, 8: 44. [Abstract] [Full-text]
28. Dynamics and control of measles in Portugal: Accessing the impact of anticipating the age for the first dose of MMR from 15 to 12 months of age.
    Vaccine, 26(19): 2418-27. [Abstract] [Full-text]
29. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
    Vaccine, 26(18): 2234-41. [Abstract] [Full-text]
30. Phylogenetic analysis of rubella viruses found in Morocco, Uganda, Cote d'Ivoire and South Africa from 2001 to 2007.
    J Clin Virol, 42(1): 86-90. [Abstract] [Full-text]
31. Evaluation of three methods assessing the relative value of a dental program.
    Acta Odontol Scand, 66(2): 82-7. [Abstract] [Full-text]
32. Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey.
    Autism, 12(3): 293-307. [Abstract] [Full-text]
33. Mumps vaccine performance among university students during a mumps outbreak.
    Clin Infect Dis, 46(8): 1172-80. [Abstract] [Full-text]

© 2004-2010 Measles Research Today. All Rights Reserved.